Currently Browsing
Our Products
Aurobindo Receives FDA Approval for Niacin Extended-Release Tablets USP
Overview
- Reference Brand:
- Therapeutic Class:
Specifications
Order Information
Attributes
- Physical Form:
February 09, 2024 | Aurobindo Receives FDA Approval for Deflazacort Tablets 6mg, 18mg, 30mg, & 36mg ... Read more
September 06, 2023 | Aurobindo Receives FDA Approval for Loperamide Hydrochloride Capsules USP 2mg ... Read more
August 18, 2023 | Aurobindo Receives FDA Approval for Fluphenazine Hydrochloride Tablets 1mg, 2.5mg, 5mg, and 10mg ... Read more